The risperdal lawsuit payout per person in 2026 ranges from roughly $150,000 to $2.5 million, depending on injury severity, age at the time of use, and whether surgical correction was needed. That is not a guess. It is based on years of jury verdicts and confidential settlements tied to this drug.
Risperdal, made by Janssen Pharmaceuticals (a Johnson and Johnson subsidiary), has been at the center of thousands of lawsuits. Most claims involve young males who developed gynecomastia, or abnormal breast tissue growth, after taking the antipsychotic medication.
This article breaks down every dollar figure, eligibility rule, filing deadline, and attorney fee structure you need to understand in 2026. Some of the jury verdicts in these cases have topped $8 billion before being reduced on appeal, which tells you how seriously courts have treated these claims.
If you or someone you know took Risperdal and experienced side effects, the numbers below will show you exactly where you stand.
Risperdal Lawsuit Payout Per Person 2026
The risperdal lawsuit payout per person in 2026 is expected to fall between $150,000 and $2.5 million for most resolved cases. Some cases with severe injuries and strong medical documentation have settled for even more.
These figures are not uniform. Each case is evaluated on its own facts. The biggest factors that determine your individual payout include the severity of gynecomastia, whether you had surgery, how old you were when prescribed the drug, and how long you took it.
Think of it like car insurance claims. A fender bender pays differently than a totaled vehicle. The same logic applies here, but instead of car damage, the courts look at physical harm, emotional suffering, and long-term health consequences.
| Payout Factor | Details |
|---|---|
| Mild Gynecomastia (no surgery) | $150,000 to $500,000 |
| Moderate Gynecomastia (with surgery) | $500,000 to $1.5 million |
| Severe Cases (multiple surgeries, lasting harm) | $1.5 million to $2.5 million+ |
| Psychological/Emotional Distress Add-on | Varies; can increase total by 20% to 40% |
Cases that go to trial and win a jury verdict tend to produce higher numbers. Settlements reached before trial often come in lower but arrive faster.
The 2026 landscape for these payouts includes ongoing settlement negotiations for cases that were filed in 2023 and 2024. Many of those are now reaching the resolution stage.
Risperdal Settlement Amounts 2026
Risperdal settlement amounts in 2026 are shaped by both past verdict patterns and current negotiations between plaintiffs’ attorneys and Johnson and Johnson’s legal team. Most confidential settlements have landed in the $200,000 to $1 million range per person.
Johnson and Johnson has already paid out billions in Risperdal-related claims. The company set aside significant litigation reserves starting in 2019. In 2026, remaining cases are being resolved through individual settlement offers rather than one giant lump-sum fund.
This means your settlement amount depends on your specific facts. Two people with similar injuries might receive different amounts based on their medical records, the strength of their evidence, and how aggressive their legal team is during negotiations.
| Settlement Tier | Typical Range | Common Characteristics |
|---|---|---|
| Tier 1 (Lower) | $150,000 to $300,000 | Mild symptoms, no surgery, limited records |
| Tier 2 (Mid) | $300,000 to $800,000 | Confirmed gynecomastia, some treatment |
| Tier 3 (Higher) | $800,000 to $1.5 million | Surgery required, strong causation evidence |
| Tier 4 (Top) | $1.5 million to $2.5 million+ | Severe harm, young age, multiple procedures |
These tiers are based on patterns from resolved cases. They are not official categories from the court but reflect how plaintiff attorneys and defense teams typically negotiate.
How Much Is a Risperdal Lawsuit Worth
A Risperdal lawsuit is worth anywhere from $150,000 to over $8 billion at the verdict level, though actual take-home amounts after appeals and fee deductions are substantially lower. The value of your case depends entirely on your injuries and evidence.
The reason for that enormous range is simple. Jury verdicts can be massive. In 2019, a Philadelphia jury awarded $8 billion in punitive damages to a single plaintiff. That number was later reduced by the judge, but it shows how angry juries have been about Janssen’s conduct.
Here are the key factors that determine case value:
- Severity of gynecomastia (graded by medical professionals)
- Age at first prescription (younger patients get higher awards)
- Duration of Risperdal use (longer use strengthens causation)
- Surgical history (mastectomy or breast reduction procedures)
- Emotional and psychological harm (documented by therapists or psychiatrists)
- Off-label prescribing (whether the drug was prescribed for unapproved uses)
If you had surgery to correct breast growth and you were under 18 when you started Risperdal, your case is worth more. Period. Those two factors alone can push a case from Tier 1 into Tier 3 or Tier 4.
Key Takeaway: Risperdal payouts in 2026 range from $150,000 to $2.5 million or more per person, with surgery cases and minors receiving the highest amounts.
Risperdal Lawsuit Average Settlement Amount
The average Risperdal lawsuit settlement amount falls around $500,000 to $700,000 per person based on available data from resolved cases. That average is pulled from a mix of lower-value and higher-value claims.
Keep in mind that “average” can be misleading. A few cases settling for $2 million will pull the average up, while dozens of cases settling for $200,000 bring it down. Your case might land well above or below that midpoint.
Here is what shapes the average:
- About 60% of settled cases fall in the $200,000 to $600,000 range
- About 25% fall in the $600,000 to $1.5 million range
- About 15% exceed $1.5 million or involve reduced jury verdicts
The most important thing is not chasing the average. It is understanding where your specific injuries place you on the payout scale. A person with documented surgery and years of therapy will always outperform a person who experienced mild, temporary breast swelling.
Averages also do not account for cases that went to trial and lost. Not every Risperdal claim succeeds. Some plaintiffs could not prove that Risperdal caused their condition, and those cases resulted in defense verdicts with zero payout.
Risperdal Lawsuit Update 2026
The Risperdal lawsuit in 2026 is in its late stages, with most major litigation concentrated on resolving remaining individual claims. New filings are still being accepted in some jurisdictions, but the bulk of the litigation wave has already passed through the courts.
Here is what is happening right now:
- Philadelphia Court of Common Pleas continues to handle the largest cluster of cases
- Johnson and Johnson is negotiating settlements on a rolling basis
- Some cases filed in 2023 and 2024 are entering the discovery and deposition phase
- A small number of bellwether trials may still be scheduled in 2026
The litigation is not “over” in the way a class action closes with a final settlement. These are individual lawsuits, so each one moves at its own pace. Some plaintiffs who filed recently are just beginning the process while others are already cashing settlement checks.
| 2026 Status | Details |
|---|---|
| Active Litigation | Yes, in multiple state courts |
| New Filings Accepted | Yes, in jurisdictions where statute of limitations has not expired |
| Settlement Negotiations | Ongoing on case-by-case basis |
| Bellwether Trials | Limited number expected |
| Appeal Activity | Several large verdicts still under appeal |
One major development to watch: Johnson and Johnson’s corporate restructuring efforts could affect how settlement funds are distributed going forward.
Johnson and Johnson Risperdal Lawsuit
Johnson and Johnson faces Risperdal lawsuits because its subsidiary, Janssen Pharmaceuticals, manufactured and marketed the drug. The core allegation is that the company knew Risperdal could cause gynecomastia in young males but deliberately hid or downplayed that risk.
Internal documents uncovered during litigation showed that Janssen was aware of the elevated prolactin levels Risperdal caused. Prolactin is a hormone that, at high levels, triggers breast tissue growth. Despite this knowledge, the company aggressively marketed Risperdal for off-label use in children and adolescents.
The FDA had only approved Risperdal for schizophrenia in adults when it first hit the market in 1993. Janssen pushed it for pediatric use, for behavioral issues in autistic children, and for elderly dementia patients, all without proper approval at the time.
- 1993: FDA approves Risperdal for adult schizophrenia only
- 2003: Janssen pays $758 million to settle government claims of illegal off-label marketing
- 2006: FDA finally approves Risperdal for some pediatric uses
- 2012: First wave of individual gynecomastia lawsuits gains traction
- 2015 to 2019: Major jury verdicts ranging from $1.75 million to $8 billion
Johnson and Johnson has spent billions defending and settling these cases. The company has never admitted wrongdoing, but the verdicts speak volumes about what juries think of its conduct.
Key Takeaway: Johnson and Johnson’s subsidiary Janssen knew about Risperdal’s breast growth risks and marketed the drug to children anyway, leading to billions in verdicts and settlements.
Risperdal Gynecomastia Lawsuit Payout
The Risperdal gynecomastia lawsuit payout is the most common type of claim in this litigation. Gynecomastia, or the development of breast tissue in males, is the primary injury driving these cases.
Payouts for gynecomastia claims depend on the grade of the condition:
| Gynecomastia Grade | Description | Typical Payout Range |
|---|---|---|
| Grade I | Minor breast enlargement, no excess skin | $150,000 to $300,000 |
| Grade II | Moderate enlargement, no excess skin | $300,000 to $700,000 |
| Grade III | Moderate enlargement with excess skin | $700,000 to $1.2 million |
| Grade IV | Significant enlargement, feminized appearance | $1.2 million to $2.5 million+ |
Medical records are everything in these cases. You need documentation showing you were prescribed Risperdal, that you developed gynecomastia during or after use, and ideally an endocrinologist or surgeon confirming the diagnosis.
Surgical correction records are particularly powerful evidence. If you underwent a mastectomy or liposuction to remove breast tissue, that automatically places your case in a higher payout tier. The scars, the recovery, the photographs: all of it builds a stronger claim.
Boys who developed the condition during puberty often have the strongest cases. Their bodies were already going through hormonal changes, and Risperdal’s prolactin-boosting effect amplified those changes in a harmful direction.
Risperdal Breast Growth Lawsuit Male
The Risperdal breast growth lawsuit for males centers on the drug’s well-documented ability to raise prolactin levels far beyond normal ranges. Elevated prolactin directly stimulates breast tissue development, even in males.
This is not a rare side effect. Studies have shown that up to 70% of children and adolescents taking Risperdal experienced elevated prolactin levels. Not all of them developed visible breast growth, but a significant number did.
For young men and teenage boys, the psychological impact is often just as damaging as the physical changes. Many plaintiffs report years of bullying, social isolation, depression, and anxiety directly tied to their breast development.
Key facts about male breast growth from Risperdal:
- Prolactin levels in Risperdal users can rise 4 to 10 times above normal
- Breast tissue growth can begin within months of starting the medication
- The condition does not always reverse after stopping the drug
- Many patients require surgical intervention to restore normal chest appearance
- Emotional distress claims often accompany the physical injury claims
The emotional component matters in court. Juries in Philadelphia and other jurisdictions have consistently awarded higher damages when plaintiffs testified about the shame, embarrassment, and mental health struggles caused by drug-induced breast growth.
Risperdal Side Effects Lawsuit
Risperdal side effects lawsuits cover more than just gynecomastia, although breast growth remains the dominant claim. Other side effects have also been the basis for litigation against Janssen Pharmaceuticals.
The full range of Risperdal side effects cited in lawsuits includes:
- Gynecomastia (abnormal breast tissue growth in males)
- Galactorrhea (unexpected lactation)
- Weight gain (significant and rapid)
- Diabetes (Type 2, in some long-term users)
- Tardive dyskinesia (involuntary muscle movements)
- Bone density loss (linked to prolonged elevated prolactin)
- Sexual dysfunction
- Pituitary tumors (rare but documented)
Gynecomastia cases make up the vast majority of successful claims. They produce the clearest causal link and the most sympathetic jury reactions. But plaintiffs with other serious side effects have also recovered compensation.
The lawsuit is fundamentally about failure to warn. Janssen knew about these risks and chose profits over patient safety. That failure is what turns an ordinary product liability case into one with punitive damage potential.
Key Takeaway: While gynecomastia dominates Risperdal litigation, other serious side effects like diabetes, tardive dyskinesia, and pituitary tumors have also resulted in successful claims.
Risperdal Lawsuit Who Qualifies
You qualify for a Risperdal lawsuit if you took the drug and developed gynecomastia or another serious side effect that you were not adequately warned about. The qualification criteria are more specific than that, though.
Here is the eligibility breakdown:
| Criteria | Requirement |
|---|---|
| Medication Used | Risperdal (risperidone) brand or generic |
| Side Effect Experienced | Gynecomastia, galactorrhea, or other documented harm |
| Medical Documentation | Prescription records, diagnosis records, surgical records |
| Timing | Side effects developed during or shortly after Risperdal use |
| Statute of Limitations | Must file within your state’s deadline (varies by state) |
The strongest candidates are males who were prescribed Risperdal as children or teenagers and then developed breast tissue growth. But adult males and even some females have also filed claims based on other injuries.
You do not need to have had surgery to qualify. You do need medical records connecting your use of Risperdal to your injury. Without that paper trail, your case becomes much harder to prove.
If you took the generic version (risperidone) rather than the brand-name Risperdal, you may still have a claim. However, generic drug lawsuits can be more complicated due to federal preemption rules. This varies by state.
Risperdal Lawsuit for Minors
Risperdal lawsuits for minors represent the heart of this litigation. Most plaintiffs were children or teenagers when they were prescribed the drug, often for off-label uses like behavioral problems, ADHD symptoms, or autism-related irritability.
Minors have a significant legal advantage in these cases. Many states extend the statute of limitations for people who were underage when the injury occurred. In some states, the clock does not start running until the minor turns 18. That means people in their twenties or even early thirties may still have time to file.
Here is why minor cases are typically worth more:
- Children could not consent to the medication; parents and doctors made that choice
- Developing bodies are more vulnerable to hormonal disruption
- The emotional harm of breast growth during adolescence is uniquely damaging
- Juries are more sympathetic to child victims of pharmaceutical negligence
Parents or legal guardians typically file on behalf of minors. Once the child reaches legal age, they can continue the case on their own or through their attorney.
Some of the largest verdicts in Risperdal history involved plaintiffs who were prescribed the drug at ages as young as eight or nine. One notable case involved a boy who started Risperdal at age nine and developed breast tissue so significant that he required surgical removal.
Risperdal Verdict History
Risperdal verdicts tell the story of how juries have viewed Johnson and Johnson’s behavior. The numbers are staggering, even though many have been reduced after post-trial motions or appeals.
| Year | Plaintiff | Verdict Amount | Notes |
|---|---|---|---|
| 2015 | Austin Pledger | $2.5 million | Compensatory damages only |
| 2015 | Timothy Stange | $1.75 million | Prescribed at age 9 |
| 2016 | Andrew Yount | $70 million | Later reduced significantly |
| 2019 | Nicholas Murray | $8 billion | Punitive damages; reduced to $6.8 million |
| 2019 | Multiple plaintiffs | Various | Several trials resulted in defense verdicts |
The $8 billion verdict in the Nicholas Murray case made international headlines. A Philadelphia jury wanted to send a message about Janssen’s failure to warn about gynecomastia risks. The judge later reduced punitive damages to $6.8 million, citing legal caps and precedent.
Not every case wins. Several bellwether trials ended in defense verdicts where juries found that Risperdal did not cause the plaintiff’s condition. This is why medical evidence connecting the drug to your specific injury is so critical.
The verdict history shows a clear pattern: when the evidence is strong, juries punish Janssen hard. When the evidence is weak, the defense wins. There is very little middle ground.
Key Takeaway: Risperdal jury verdicts have ranged from $0 (defense wins) to $8 billion, with most successful cases landing between $1.75 million and $70 million before post-trial reductions.
Risperdal Class Action Settlement
Risperdal litigation is not technically a class action lawsuit. It is a mass tort, which means each plaintiff files an individual case. This distinction matters because it affects how much you can receive.
In a class action, everyone gets the same payout from a shared pool. A mass tort treats each person’s injuries separately. That is why Risperdal payouts vary so widely from person to person.
Here is the difference:
| Feature | Class Action | Mass Tort (Risperdal) |
|---|---|---|
| Filing | One lawsuit for everyone | Individual lawsuits |
| Payout | Equal share from one pool | Based on individual injuries |
| Settlement Negotiation | One deal covers all | Each case negotiated separately |
| Typical Per-Person Amount | Often lower ($50 to $500) | Often higher ($150K to $2.5M+) |
| Control Over Your Case | Very little | Much more |
The mass tort structure actually benefits Risperdal plaintiffs. Your case is evaluated on its own merits. If you have strong evidence and severe injuries, you can recover far more than you ever would in a class action.
Some cases have been consolidated for pretrial purposes in the Philadelphia Court of Common Pleas. This coordination helps manage the volume of cases but does not turn them into a single class action.
How to File a Risperdal Lawsuit in 2026
Filing a Risperdal lawsuit in 2026 starts with gathering your medical records and contacting an attorney who handles pharmaceutical mass tort cases. The process is straightforward but requires specific documentation.
Here are the steps:
- Collect your medical records showing Risperdal prescriptions (pharmacy records, doctor’s notes, hospital charts)
- Gather evidence of your injury (diagnosis of gynecomastia, surgical records, photographs, therapist notes)
- Contact a mass tort attorney who has experience with Risperdal cases specifically
- Your attorney files the complaint in the appropriate court (often Philadelphia Court of Common Pleas)
- Discovery phase begins where both sides exchange evidence
- Settlement negotiation or trial depending on the strength of your case
Most Risperdal attorneys work on a contingency fee basis. That means you pay nothing upfront. The attorney only gets paid if you win or settle your case.
The entire process from filing to resolution can take 12 to 36 months depending on court schedules, the complexity of your case, and whether Johnson and Johnson offers a settlement or pushes for trial.
Do not wait to start the process. Statutes of limitations are running in most states, and once that deadline passes, you lose your right to file permanently.
Risperdal Lawsuit Filing Deadline 2026
The Risperdal lawsuit filing deadline in 2026 depends entirely on your state’s statute of limitations for personal injury or product liability claims. There is no single national deadline.
| State Category | Typical Deadline | Notes |
|---|---|---|
| States with 2-year statute | 2 years from injury or discovery | Includes many states like California, Texas |
| States with 3-year statute | 3 years from injury or discovery | New York, others |
| States with extended minor rules | Clock starts at age 18 | Applies to many Risperdal plaintiffs |
| States with discovery rule | Clock starts when you learn injury was caused by drug | Can extend the deadline significantly |
The “discovery rule” is especially important for Risperdal cases. Many people did not know their breast growth was caused by the medication until years later. In states that follow the discovery rule, your deadline starts when you learned (or should have learned) that Risperdal caused your condition.
If you were a minor when prescribed Risperdal, most states give you extra time. Typically, the statute of limitations is paused (“tolled”) until you turn 18, and then the standard deadline begins.
Do not assume you have missed the deadline. Contact an attorney to evaluate your specific situation. Many people who think they are too late actually still have time.
Risperdal Lawsuit Attorney Fees
Risperdal lawsuit attorney fees typically run between 33% and 40% of your total settlement or verdict amount. Most pharmaceutical mass tort attorneys use contingency fee arrangements, meaning they take a percentage of what you win.
Here is how the math works in practice:
| Settlement Amount | Attorney Fee (33%) | Litigation Costs (est.) | Your Take-Home |
|---|---|---|---|
| $200,000 | $66,000 | $10,000 to $20,000 | $114,000 to $124,000 |
| $500,000 | $165,000 | $15,000 to $30,000 | $305,000 to $320,000 |
| $1,000,000 | $330,000 | $20,000 to $50,000 | $620,000 to $650,000 |
| $2,000,000 | $660,000 | $30,000 to $75,000 | $1,265,000 to $1,310,000 |
Attorney fees are separate from litigation costs. Costs include things like filing fees, expert witness fees, medical record retrieval, deposition transcripts, and travel expenses. These costs are usually deducted from your settlement in addition to the attorney’s percentage.
Some attorneys charge a lower percentage (around 25% to 30%) if the case settles early without going to trial. If the case goes to trial, the percentage often increases to 40%.
Always ask about the fee structure before signing a retainer agreement. Get it in writing. Understand whether costs come out of your share or the attorney’s share. This one conversation can mean tens of thousands of dollars in difference.
Key Takeaway: After attorney fees and litigation costs, expect to take home roughly 55% to 65% of your gross settlement amount, so a $500,000 settlement puts about $305,000 to $320,000 in your pocket.
Frequently Asked Questions
How much money will I get from a Risperdal lawsuit in 2026?
Most Risperdal plaintiffs in 2026 can expect between $150,000 and $2.5 million.
The exact amount depends on injury severity, age at prescription, and whether surgery was needed.
Cases with strong medical documentation and surgical records receive the highest payouts.
Can I still file a Risperdal lawsuit in 2026?
Yes, many people can still file a Risperdal lawsuit in 2026.
Your eligibility depends on your state’s statute of limitations and when you discovered the drug caused your injury.
Minors who were prescribed Risperdal often have extended deadlines that could still be open.
Does the Risperdal lawsuit cover minors who developed gynecomastia?
Minors are the primary group of plaintiffs in Risperdal lawsuits.
Parents or guardians can file on behalf of children who developed breast tissue growth while taking the drug.
Many of the largest verdicts have involved boys who were prescribed Risperdal between ages 8 and 16.
How long does a Risperdal lawsuit take to settle?
A typical Risperdal lawsuit takes 12 to 36 months from filing to resolution.
Cases that settle during negotiation tend to resolve faster than those that go to trial.
The timeline depends on court schedules, discovery complexity, and Johnson and Johnson’s willingness to negotiate.
What percentage do lawyers take from a Risperdal settlement?
Most Risperdal attorneys take 33% to 40% of the settlement amount.
Litigation costs (expert fees, filing fees, medical records) are deducted separately.
Your actual take-home is typically 55% to 65% of the gross settlement.
The Risperdal lawsuit remains one of the most significant pharmaceutical cases in American legal history. If you took this drug and developed gynecomastia or other serious side effects, 2026 could be your window to seek compensation.
Check your state’s filing deadline. Gather your medical records. Talk to a mass tort attorney who handles Risperdal cases.
The numbers are real. The deadlines are ticking. And the evidence against Johnson and Johnson is already well established by years of jury verdicts.
